[1]Patent:WO2017/76742,2017,A1
171876-65-6 | Piperazine 3-(4-hydroxy-3-methoxyphenyl)acrylate | AA00HZHF | MFCD03428534
609-54-1 | Benzenesulfonic acid, 2,5-dimethyl- | AA00IAOY | MFCD00064858
96308-73-5 | 3-Methyl-3-aminomethylazetidine dihydrochloride | AA00IJPZ | MFCD09264501
1993095-02-5 | 3-(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)propanoic acid hydrochloride | AA00J11Q | MFCD26959488
374918-94-2 | 4-methyl-7-phenoxy-1H,2H,3H,4H,9H-cyclopenta[b]quinolin-9-one | AA01A29K | MFCD02115681
1795504-80-1 | 4,4-Dimethylpyrrolidin-3-ol hydrochloride | AA01BG2R | MFCD22690621
10319-14-9 | 1H-Indene-1,3(2H)-dione, 2-(4-bromo-3-hydroxy-2-quinolinyl)- | AA01DNP7 | MFCD00071862
1346601-49-7 | Metaproterenol-d7HemisulfateSalt | AA01E1AK
1048039-15-1 | N-(1-adamantyl)-4-oxo-1-pentyl-6-phenylquinoline-3-carboxamide | AA01FG7Z | MFCD27991277
2102202-96-8 | B-[4-[[(2-methylpropyl)amino]sulfonyl]phenyl]Boronic acid | AA01FPRS | MFCD28396569
5671-85-2
58805-02-0
850910-15-5
929429-34-5
1226445-15-3
2380183-23-1